Faraj Nakhleh
Vorsitzender bei EMERGIA INC.
Aktive Positionen von Faraj Nakhleh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EMERGIA INC. | Vorsitzender | 16.04.2024 | - |
Direktor/Vorstandsmitglied | 01.06.2022 | 16.04.2024 | |
Independent Dir/Board Member | 01.06.2022 | 16.04.2024 | |
Trak Concepts, Inc. | Vorstandsvorsitzender | 09.10.2009 | - |
Präsident | 09.10.2009 | - |
Karriereverlauf von Faraj Nakhleh
Ehemalige bekannte Positionen von Faraj Nakhleh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Direktor/Vorstandsmitglied | 30.06.2010 | 08.04.2011 |
Raymond Chabot Grant Thornton LLP
Raymond Chabot Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Raymond Chabot Grant Thornton LLP engages in the provision of tax, recovery and organization, management consulting, financial advisory, digital and technology, assurance and human resource consulting services. It serves the tourism, leisure and culture, natural resources, mining and forestry, manufacturing, and retail and distribution industry. The company was founded in 1948 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | 09.10.2009 | - |
NTI Newmerical, Inc.
NTI Newmerical, Inc. Packaged SoftwareTechnology Services NTI Newmerical, Inc. develops advanced CFD multi-disciplinary simulation software for the aeronautics, automotive, marine and power and process industries. It develops and provides in-flight icing simulation software and associated design, testing and certification services to aerospace companies desirous to apply safety standards that meet and exceed regulations. It was founded by Wagdi G. Habashi is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | 26.10.2001 | - |
Ausbildung von Faraj Nakhleh
McGill University | Graduate Degree |
Robert College | Undergraduate Degree |
Statistik
International
Kanada | 6 |
Vereinigte Staaten | 2 |
Türkei | 2 |
Operativ
Director/Board Member | 3 |
Chief Executive Officer | 1 |
President | 1 |
Sektoral
Consumer Services | 3 |
Technology Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EMERGIA INC. | Finance |
Private Unternehmen | 4 |
---|---|
NTI Newmerical, Inc.
NTI Newmerical, Inc. Packaged SoftwareTechnology Services NTI Newmerical, Inc. develops advanced CFD multi-disciplinary simulation software for the aeronautics, automotive, marine and power and process industries. It develops and provides in-flight icing simulation software and associated design, testing and certification services to aerospace companies desirous to apply safety standards that meet and exceed regulations. It was founded by Wagdi G. Habashi is headquartered in Montreal, Canada. | Technology Services |
Raymond Chabot Grant Thornton LLP
Raymond Chabot Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Raymond Chabot Grant Thornton LLP engages in the provision of tax, recovery and organization, management consulting, financial advisory, digital and technology, assurance and human resource consulting services. It serves the tourism, leisure and culture, natural resources, mining and forestry, manufacturing, and retail and distribution industry. The company was founded in 1948 and is headquartered in Montreal, Canada. | Commercial Services |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
Trak Concepts, Inc. |
- Börse
- Insiders
- Faraj Nakhleh
- Erfahrung